Jeremy Grantham Quest Diagnostics Inc Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$31.4 Billion
Q3 2024

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 2,242,776 shares of DGX stock, worth $307 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

2,242,776

Previous 2,128,721 5.36%

Holding current value

$307 Million

Previous $291 Million 5.52%

% of portfolio

0.98%

Previous 1.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$137.09 - $137.09 $15.6 Million - $15.6 Million	114,055 Added 5.36%	2,242,776 $307 Million
Q2 2024 Aug 13, 2024	BUY	$125.91 - $144.34 $10.8 Million - $12.3 Million	85,466 Added 4.18%	2,128,721 $291 Million
Q1 2024 May 14, 2024	BUY	$123.78 - $142.11 $41.9 Million - $48 Million	338,108 Added 19.83%	2,043,255 $272 Million
Q4 2023 Feb 13, 2024	BUY	$120.62 - $141.12 $8.29 Million - $9.7 Million	68,740 Added 4.2%	1,705,147 $235 Million
Q3 2023 Nov 13, 2023	BUY	$121.86 - $144.92 $4.64 Million - $5.51 Million	38,041 Added 2.38%	1,636,407 $199 Million
Q2 2023 Aug 14, 2023	BUY	$130.56 - $146.84 $13.1 Million - $14.7 Million	100,333 Added 6.7%	1,598,366 $225 Million
Q1 2023 May 12, 2023	BUY	$131.53 - $155.76 $1.95 Million - $2.31 Million	14,800 Added 1.0%	1,498,033 $212 Million
Q4 2022 Feb 13, 2023	SELL	$123.31 - $157.26 $26.6 Million - $33.9 Million	-215,400 Reduced 12.68%	1,483,233 $232 Million
Q3 2022 Nov 10, 2022	SELL	$121.77 - $141.1 $4.5 Million - $5.22 Million	-36,962 Reduced 2.13%	1,698,633 $208 Million
Q2 2022 Aug 12, 2022	SELL	$127.07 - $145.39 $4.34 Million - $4.97 Million	-34,160 Reduced 1.93%	1,735,595 $231 Million
Q1 2022 May 13, 2022	SELL	$129.09 - $164.35 $1.18 Million - $1.51 Million	-9,169 Reduced 0.52%	1,769,755 $242 Million
Q4 2021 Feb 11, 2022	BUY	$140.36 - $173.01 $781,664 - $963,492	5,569 Added 0.31%	1,778,924 $308 Million
Q3 2021 Nov 12, 2021	BUY	$132.95 - $158.0 $7.61 Million - $9.05 Million	57,258 Added 3.34%	1,773,355 $258 Million
Q2 2021 Aug 12, 2021	BUY	$126.66 - $141.48 $22.4 Million - $25 Million	176,742 Added 11.48%	1,716,097 $226 Million
Q1 2021 May 13, 2021	SELL	$114.63 - $133.34 $1.36 Million - $1.58 Million	-11,859 Reduced 0.76%	1,539,355 $198 Million
Q4 2020 Feb 12, 2021	BUY	$112.7 - $128.05 $33,697 - $38,286	299 Added 0.02%	1,551,214 $185 Million
Q3 2020 Nov 13, 2020	SELL	$107.05 - $130.01 $12.5 Million - $15.2 Million	-117,088 Reduced 7.02%	1,550,915 $178 Million
Q2 2020 Aug 13, 2020	BUY	$73.34 - $122.61 $21.6 Million - $36.2 Million	294,903 Added 21.48%	1,668,003 $190 Million
Q1 2020 May 14, 2020	BUY	$75.14 - $115.68 $103 Million - $159 Million	1,373,100 New	1,373,100 $110 Million
Q4 2018 Feb 13, 2019	SELL	$79.75 - $108.38 $183,425 - $249,274	-2,300 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$96.42 - $107.88 $144,630 - $161,820	-1,500 Reduced 39.47%	2,300 $231,000
Q4 2017 Feb 14, 2018	SELL	$90.86 - $100.24 $63,602 - $70,168	-700 Reduced 15.56%	3,800 $374,000
Q3 2017 Nov 14, 2017	BUY	$91.96 - $108.35 $156,332 - $184,195	1,700 Added 60.71%	4,500 $421,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,800	2,800 $311,000

Others Institutions Holding DGX

# of Institutions

923

Shares Held

95M

Call Options Held

379K

Put Options Held

354K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account